Therapies are developed for the “average” patient, even though there is no such thing. Scipher is breaking this law of averages to ensure patients get the right treatment from day one.
Our diagnostic tests identify patients who will not respond to a specific targeted drug so they can be prescribed an alternative treatment. As autoimmune diseases are progressive, time is invaluable to the patient.
Our tests require a small blood or tissue sample from the patient
RNA is extracted from the sample and analyzed
The test determines if the patient’s RNA profile is a better match to a “responder” or “non-responder”.
PrismRA identifies rheumatoid arthritis patients who will not respond to anti-TNFs
PrismUC predicts non-response to anti-TNFs for patients with ulcerative colitis
Both tests have been shown to identify at least half of patients who will not respond to anti-TNFs with at least 90% accuracy, performance requirements set by rheumatologists and gastroenterologists.